NEW YORK, Aug. 27, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Calumet, Inc. ("Calumet" or the "Company") (NASDAQ: CLMT). Such investors are advised to contac

Calumet delivered a stellar quarter, outperforming analyst expectations and confirming a strong operational turnaround. MRL's revised SAF expansion leverages existing assets, accelerating volume ramp
Calumet, Inc. (CLMT) Q2 2026 Earnings Call Transcript